Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

NCT05991388 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT05991388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05991388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Lead sponsor
University of Birmingham
Phase
Phase 2/3
Overall status
Recruiting
Start date
May 2, 2024
Completion date
May 1, 2033
Enrollment
210 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell non hodgkin lymphoma